Structure-based discovery of CZL80, a caspase-1 inhibitor with therapeutic potential for febrile seizures and later enhanced epileptogenic susceptibility.
Yangshun TangBo FengYi WangHuiyong SunYi YouJie YuBin ChenCenglin XuYeping RuanSunliang CuiGang HuTingjun HouZhong ChenPublished in: British journal of pharmacology (2020)
Caspase-1 is essential for FS generation. CZL80 is a promising low MW inhibitor of FS and later enhanced epileptogenic susceptibility.